Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries

被引：0
|
作者：
Manuel Hens
Ana Villaverde-Hueso
Veronica Alonso
Ignacio Abaitua
Manuel Posada de la Paz
机构：
[1] Instituto de Salud Carlos III,Rare Diseases Research Institute
[2] Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER),undefined
来源：
The European Journal of Health Economics | 2014年 / 15卷
关键词：
Migraine; Therapy; Triptans; Cost-effectiveness; Health economics; Treatment; I10; I13; I18;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：433 / 437
页数：4
相关论文
共 50 条
  • [31] Cost-effectiveness of migraine treatment: A commentary
    Smith, DG
    VALUE IN HEALTH, 2003, 6 (04) : 436 - 437
  • [32] Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation-results from four European countries
    Bolin, Kristian
    Wilson, Koo
    Benhaddi, Hicham
    de Nigris, Enrico
    Marbaix, Sophie
    Mork, Ann-Christin
    Aubin, Henri-Jean
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2009, 19 (06): : 650 - 654
  • [33] Cost-effectiveness of Campylobacter interventions on broiler farms in six European countries
    van Wagenberg, C. P. A.
    van Horne, P. L. M.
    Sommer, H. M.
    Nauta, M. J.
    MICROBIAL RISK ANALYSIS, 2016, 2-3 : 53 - 62
  • [34] An exploratory study of the cost-effectiveness of orthodontic care in seven European countries
    Deans, Jamie
    Playle, Rebecca
    Durning, Peter
    Richmond, Stephen
    EUROPEAN JOURNAL OF ORTHODONTICS, 2009, 31 (01) : 90 - 94
  • [35] Cost-effectiveness and comparative effectiveness of biologic therapy for asthma To biologic or not to biologic?
    Anderson, William C., III
    Szefler, Stanley J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 122 (04) : 367 - 372
  • [36] COST-EFFECTIVENESS ANALYSIS OF FOUR EMBRYO TRANSFER STRATEGIES
    You, J.
    Lok, I. H.
    VALUE IN HEALTH, 2010, 13 (03) : A183 - A183
  • [37] A COST-EFFECTIVENESS ANALYSIS OF BIOSIMILAR INFLIXIMAB (INFLECTRAO) FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN NINE EUROPEAN COUNTRIES
    Rencz, F.
    Brodszky, V
    Pentek, M.
    Gulacsi, L.
    Baji, P.
    VALUE IN HEALTH, 2016, 19 (07) : A540 - A541
  • [38] A COST-EFFECTIVENESS ANALYSIS OF BIOSIMILAR INFLIXIMAB (INFLECTRA®) FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS IN NINE EUROPEAN COUNTRIES
    Rencz, F.
    Brodszky, V
    Pentek, M.
    Gulacsi, L.
    Baji, P.
    VALUE IN HEALTH, 2016, 19 (07) : A540 - A540
  • [39] Cost-effectiveness analysis of timolol latanoprost and travoprost in 3 European countries: The UK, Germany and France
    Lilliu, H
    Ligier, M
    Le Pen, C
    Berdeaux, G
    VALUE IN HEALTH, 2003, 6 (06) : 640 - 640
  • [40] Modeling the Cost-Effectiveness of Successive Preventive Oral Medication Trials in Chronic Migraine
    Ney, J.
    Guirguis, A.
    Dao, V
    Sico, J.
    HEADACHE, 2023, 63 : 195 - 196
12345